HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy

Recent studies suggest that CLL is an immunogenic disease, which might be effectively targeted by antigen-specific T-cell-based immunotherapy. However, CLL is associated with a profound immune defect, which might represent a critical limitation for mounting clinically effective antitumor immune resp...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Nelde, Annika, Kowalewski, Daniel J., Backert, Linus, Schuster, Heiko, Werner, Jan-Ole, Klein, Reinhild, Kohlbacher, Oliver, Kanz, Lothar, Salih, Helmut R., Rammensee, Hans-Georg, Stevanović, Stefan, Walz, Juliane S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889201/
https://ncbi.nlm.nih.gov/pubmed/29632711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1316438
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak